C型ニーマン・ピック病治療の世界市場レポート 2025年

C型ニーマン・ピック病治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.1％で41億4,000万米ドルに成長します。予測期間中に予測される成長は、研究開発活動の増加、パイプライン医薬品の増加、希少疾患の高い有病率、遺伝子治療の人気の高まり、遺伝子治療の著しい進歩に起因しています。この期間の主な動向としては、技術の進歩、ライソゾーム貯蔵障害に対する個別化医療の台頭、遺伝子・分子研究の進展、バイオテクノロジーの飛躍的進歩、革新的治療薬の開発などが挙げられます。

アルツハイマー病の有病率の増加は、ニーマン・ピック病C型（NPC）治療市場の拡大を加速すると予想されます。アルツハイマー病は進行性の神経変性疾患であり、脳内にβアミロイド斑やタウタンパク質のもつれが蓄積し、認知機能の低下、記憶力の低下、日常生活機能の障害を引き起こし、最終的には重度の認知症や神経変性に至ることが特徴です。アルツハイマー病の有病率が増加しているのは、世界人口の高齢化によるところが大きいです。特に先進国では、平均寿命が延びるにつれて、アルツハイマー病のような加齢に関連する疾患のリスクも上昇します。NPC治療は、ライソゾーム貯蔵障害や脂質代謝異常に関する知見を提供することで、アルツハイマー病調査に貢献しています。例えば、2024年5月、英国を拠点とする健康団体であるアルツハイマー病協会（Alzheimer's Society）は、英国では2024年に98万2千人が認知症を患い、3分の1以上が未診断であると推定しています。この数は2040年までに140万人に達すると予想されています。したがって、アルツハイマー病の有病率の増加がニーマン・ピック病C型治療市場の成長を牽引しています。

C型ニーマン・ピック病（NPC）治療市場の主要企業は、疾患の進行を遅らせ、患者の予後を改善することを目的とした神経保護治療などの革新的な治療法の開発に注力しています。神経保護療法は、脳や神経系を損傷や変性から保護し、神経変性疾患などの神経機能を維持することを目的としています。例えば、米国のバイオ医薬品会社であるイントラバイオ社は、2024年9月、米国食品医薬品局（FDA）より、ニーマン・ピック病C型（NPC）に対する初の単独治療薬であるAQNEURSA（レバセチルロイシン）の承認を取得しました。この承認は、NPC患者において12週間以内に有意な神経学的改善を示した有望な第III相試験結果に続くものです。AQNEURSAは、運動、認知、日常生活に影響を及ぼすこの稀なライソゾーム貯蔵障害に苦しむ人々に待望の治療選択肢を提供します。また、イントラバイオ社は、他の神経変性疾患や神経発達障害の治療におけるAQNEURSAの可能性を追求する予定です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界C型ニーマン・ピック病治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のC型ニーマン・ピック病治療市場：成長率分析
• 世界のC型ニーマン・ピック病治療市場の実績：規模と成長, 2019-2024
• 世界のC型ニーマン・ピック病治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界C型ニーマン・ピック病治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のC型ニーマン・ピック病治療市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ニーマン・ピック病C1型
• ニーマン・ピック病C2型
• 世界のC型ニーマン・ピック病治療市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 幼児期
• 少年
• 成人用
• 世界のC型ニーマン・ピック病治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 調査・学術機関
• 世界のC型ニーマン・ピック病治療市場ニーマン・ピック病C1型のサブセグメンテーション（型別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬物治療
• 遺伝子治療
• 基質還元療法
• 支持療法
• 世界のC型ニーマン・ピック病治療市場ニーマン・ピック病C2型のサブセグメンテーション（型別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 酵素補充療法
• 薬物治療
• 遺伝子治療
• 支持療法

第7章 地域別・国別分析

• 世界のC型ニーマン・ピック病治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のC型ニーマン・ピック病治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• C型ニーマン・ピック病治療市場：競合情勢
• C型ニーマン・ピック病治療市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
  • Boston Children's Hospital Overview, Products and Services, Strategy and Financial Analysis
  • Cincinnati Children's Hospital Medical Center Overview, Products and Services, Strategy and Financial Analysis
  • Mallinckrodt Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Myriad Genetics Inc.
• Rainbow Children's Hospital
• CENTOGENE N.V.
• The Florey Institute of Neuroscience and Mental Health
• Insilico Medicine Inc.
• National Organization for Rare Disorders（NORD）
• Zevra Therapeutics Inc.
• Azafaros A.G.
• IntraBio Inc.
• National Niemann-Pick Disease Foundation（NNPDF）
• Bloomsbury Genetic Therapies Ltd.
• CTD Holdings Inc.
• Okklo Life Sciences
• Vtesse Inc.
• Cyclo Therapeutics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• C型ニーマン・ピック病治療市場2029：新たな機会を提供する国
• C型ニーマン・ピック病治療市場2029：新たな機会を提供するセグメント
• C型ニーマン・ピック病治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Niemann-Pick disease type C (NPC) treatment refers to the medical strategies used to manage and slow the progression of Niemann-Pick disease type C, a rare inherited neurodegenerative disorder that impairs the body's ability to metabolize cholesterol and other lipids within cells. Treatment typically involves pharmacological and supportive therapies aimed at reducing neurological symptoms, stabilizing the disease, and improving the quality of life for affected individuals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of Niemann-Pick disease type C treatment focus on Niemann-Pick disease type C1 and Niemann-Pick disease type C2. Niemann-Pick disease type C1 (NPC1) is a rare, progressive, and fatal lysosomal storage disorder caused by mutations in the NPC1 gene. This leads to impaired cholesterol trafficking within cells, resulting in the accumulation of lipids in lysosomes, and causing severe neurological deterioration such as cognitive decline, motor dysfunction, and organ damage. NPC treatment spans various age groups, including infantile, juvenile, and adult populations, with end-users including hospitals, specialty clinics, and research and academic institutions.

The niemann-Pick disease type C treatment market research report is one of a series of new reports from The Business Research Company that provides niemann-Pick disease type C treatment market statistics, including niemann-Pick disease type C treatment industry global market size, regional shares, competitors with a niemann-Pick disease type C treatment market share, detailed niemann-Pick disease type C treatment market segments, market trends and opportunities, and any further data you may need to thrive in the niemann-Pick disease type C treatment industry. This niemann-Pick disease type C treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The niemann-Pick disease type C treatment market size has grown strongly in recent years. It will grow from $2.68 billion in 2024 to $2.93 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth observed during the historic period can be attributed to the expansion of healthcare infrastructure, a rising number of cases involving mutations in the NPC1 and NPC2 genes, a growing prevalence of Niemann-Pick disease, increased government funding for research into rare disease treatments, and heightened awareness and advocacy efforts.

The niemann-Pick disease type C treatment market size is expected to see strong growth in the next few years. It will grow to $4.14 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth projected during the forecast period can be attributed to increasing research and development activities, a growing number of pipeline drugs, a high prevalence of rare diseases, the emerging popularity of gene therapy, and significant advancements in genetic therapies. Key trends during this period include advancements in technology, the rise of personalized medicine for lysosomal storage disorders, progress in genetic and molecular research, breakthroughs in biotechnology, and the development of innovative therapeutics.

The growing prevalence of Alzheimer's disease is expected to accelerate the expansion of the Niemann-Pick disease type C (NPC) treatments market. Alzheimer's disease is a progressive neurodegenerative disorder characterized by the buildup of beta-amyloid plaques and tau protein tangles in the brain, leading to cognitive decline, memory loss, and difficulties with daily functioning, ultimately resulting in severe dementia and neurodegeneration. The increasing prevalence of Alzheimer's disease is largely due to the aging global population. As life expectancy increases, especially in developed nations, the risk of age-related diseases such as Alzheimer's also rises, since advancing age is the most significant known risk factor for the condition. NPC treatment contributes to Alzheimer's disease research by offering insights into lysosomal storage disorders and dysfunctions in lipid metabolism. For example, in May 2024, the Alzheimer's Society, a UK-based health organization, estimated that 982,000 people in the UK were living with dementia in 2024, with more than a third undiagnosed. This number is expected to reach 1.4 million by 2040. Therefore, the growing prevalence of Alzheimer's disease is driving the growth of the Niemann-Pick disease type C treatments market.

Leading companies in the Niemann-Pick disease type C (NPC) treatment market are focusing on developing innovative therapies, such as neuroprotective treatments, aimed at slowing disease progression and improving patient outcomes. Neuroprotective therapies are designed to protect the brain and nervous system from damage or degeneration, with the goal of preserving neurological function in conditions such as neurodegenerative diseases. For example, in September 2024, IntraBio Inc., a US-based biopharmaceutical company, received approval from the United States Food and Drug Administration (FDA) for AQNEURSA (levacetylleucine), the first stand-alone therapy for Niemann-Pick Disease Type C (NPC). This approval followed promising Phase III trial results, showing significant neurological improvements in NPC patients within 12 weeks. AQNEURSA offers a long-awaited treatment option for individuals suffering from this rare lysosomal storage disorder, which affects movement, cognition, and daily function. IntraBio also intends to explore AQNEURSA's potential in treating other neurodegenerative and neurodevelopmental disorders.

In December 2023, Cyclo Therapeutics, Inc., a US-based biotechnology firm, merged with Applied Molecular Transport Inc. for $10.2 million. This merger is aimed at strengthening Cyclo Therapeutics' financial and strategic position by utilizing additional resources, extending its financial runway, and advancing the clinical development and regulatory approval process for Trappsol Cyclo, a potential treatment for Niemann-Pick Disease Type C1 (NPC1). This treatment will undergo the pivotal Phase 3 global study (TransportNPC). Applied Molecular Transport Inc. is a US-based clinical-stage biopharmaceutical company.

Major players in the niemann-pick disease type c treatment market are Merck & Co. Inc., Mayo Clinic, Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, Mallinckrodt Pharmaceuticals, Myriad Genetics Inc., Rainbow Children's Hospital, CENTOGENE N.V., The Florey Institute of Neuroscience and Mental Health, Insilico Medicine Inc., National Organization for Rare Disorders (NORD), Zevra Therapeutics Inc., Azafaros A.G., IntraBio Inc., National Niemann-Pick Disease Foundation (NNPDF), Bloomsbury Genetic Therapies Ltd., CTD Holdings Inc., Okklo Life Sciences, Vtesse Inc., Cyclo Therapeutics Inc., Mandos Health.

North America was the largest region in the niemann-pick disease type C treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in niemann-Pick disease type C treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the niemann-Pick disease type C treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The niemann-Pick disease type C treatment market includes revenues earned by entities through medication management, symptom management, neurological care, liver care, and genetic counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Niemann-Pick Disease Type C Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on niemann-pick disease type c treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for niemann-pick disease type c treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The niemann-pick disease type c treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Niemann-Pick Diseases Type C1; Niemann-Pick Diseases Type C2
• 2) By Age Group: Infantile; Juvenile; Adult
• 3) By End-User: Hospitals; Specialty Clinics; Research And Academic Institutes
• Subsegments:
• 1) By Niemann-Pick Disease Type C1: Pharmacological Treatment; Gene Therapy; Substrate Reduction Therapy; Supportive Care
• 2) By Niemann-Pick Disease Type C2: Enzyme Replacement Therapy; Pharmacological Treatment; Gene Therapy; Supportive Care
• Companies Mentioned: Merck & Co. Inc.; Mayo Clinic; Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; Mallinckrodt Pharmaceuticals
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Niemann-Pick Disease Type C Treatment Market Characteristics

3. Niemann-Pick Disease Type C Treatment Market Trends And Strategies

4. Niemann-Pick Disease Type C Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Niemann-Pick Disease Type C Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Niemann-Pick Disease Type C Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Niemann-Pick Disease Type C Treatment Market Growth Rate Analysis
• 5.4. Global Niemann-Pick Disease Type C Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Niemann-Pick Disease Type C Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Niemann-Pick Disease Type C Treatment Total Addressable Market (TAM)

6. Niemann-Pick Disease Type C Treatment Market Segmentation

• 6.1. Global Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Niemann-Pick Diseases Type C1
• Niemann-Pick Diseases Type C2
• 6.2. Global Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infantile
• Juvenile
• Adult
• 6.3. Global Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Research And Academic Institutes
• 6.4. Global Niemann-Pick Disease Type C Treatment Market, Sub-Segmentation Of Niemann-Pick Diseases Type C1, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacological Treatment
• Gene Therapy
• Substrate Reduction Therapy
• Supportive Care
• 6.5. Global Niemann-Pick Disease Type C Treatment Market, Sub-Segmentation Of Niemann-Pick Diseases Type C2, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme Replacement Therapy
• Pharmacological Treatment
• Gene Therapy
• Supportive Care

7. Niemann-Pick Disease Type C Treatment Market Regional And Country Analysis

• 7.1. Global Niemann-Pick Disease Type C Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Niemann-Pick Disease Type C Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Niemann-Pick Disease Type C Treatment Market

• 8.1. Asia-Pacific Niemann-Pick Disease Type C Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Niemann-Pick Disease Type C Treatment Market

• 9.1. China Niemann-Pick Disease Type C Treatment Market Overview
• 9.2. China Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Niemann-Pick Disease Type C Treatment Market

• 10.1. India Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Niemann-Pick Disease Type C Treatment Market

• 11.1. Japan Niemann-Pick Disease Type C Treatment Market Overview
• 11.2. Japan Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Niemann-Pick Disease Type C Treatment Market

• 12.1. Australia Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Niemann-Pick Disease Type C Treatment Market

• 13.1. Indonesia Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Niemann-Pick Disease Type C Treatment Market

• 14.1. South Korea Niemann-Pick Disease Type C Treatment Market Overview
• 14.2. South Korea Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Niemann-Pick Disease Type C Treatment Market

• 15.1. Western Europe Niemann-Pick Disease Type C Treatment Market Overview
• 15.2. Western Europe Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Niemann-Pick Disease Type C Treatment Market

• 16.1. UK Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Niemann-Pick Disease Type C Treatment Market

• 17.1. Germany Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Niemann-Pick Disease Type C Treatment Market

• 18.1. France Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Niemann-Pick Disease Type C Treatment Market

• 19.1. Italy Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Niemann-Pick Disease Type C Treatment Market

• 20.1. Spain Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Niemann-Pick Disease Type C Treatment Market

• 21.1. Eastern Europe Niemann-Pick Disease Type C Treatment Market Overview
• 21.2. Eastern Europe Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Niemann-Pick Disease Type C Treatment Market

• 22.1. Russia Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Niemann-Pick Disease Type C Treatment Market

• 23.1. North America Niemann-Pick Disease Type C Treatment Market Overview
• 23.2. North America Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Niemann-Pick Disease Type C Treatment Market

• 24.1. USA Niemann-Pick Disease Type C Treatment Market Overview
• 24.2. USA Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Niemann-Pick Disease Type C Treatment Market

• 25.1. Canada Niemann-Pick Disease Type C Treatment Market Overview
• 25.2. Canada Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Niemann-Pick Disease Type C Treatment Market

• 26.1. South America Niemann-Pick Disease Type C Treatment Market Overview
• 26.2. South America Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Niemann-Pick Disease Type C Treatment Market

• 27.1. Brazil Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Niemann-Pick Disease Type C Treatment Market

• 28.1. Middle East Niemann-Pick Disease Type C Treatment Market Overview
• 28.2. Middle East Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Niemann-Pick Disease Type C Treatment Market

• 29.1. Africa Niemann-Pick Disease Type C Treatment Market Overview
• 29.2. Africa Niemann-Pick Disease Type C Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Niemann-Pick Disease Type C Treatment Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Niemann-Pick Disease Type C Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Niemann-Pick Disease Type C Treatment Market Competitive Landscape And Company Profiles

• 30.1. Niemann-Pick Disease Type C Treatment Market Competitive Landscape
• 30.2. Niemann-Pick Disease Type C Treatment Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Boston Children's Hospital Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Cincinnati Children's Hospital Medical Center Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Mallinckrodt Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

31. Niemann-Pick Disease Type C Treatment Market Other Major And Innovative Companies

• 31.1. Myriad Genetics Inc.
• 31.2. Rainbow Children's Hospital
• 31.3. CENTOGENE N.V.
• 31.4. The Florey Institute of Neuroscience and Mental Health
• 31.5. Insilico Medicine Inc.
• 31.6. National Organization for Rare Disorders (NORD)
• 31.7. Zevra Therapeutics Inc.
• 31.8. Azafaros A.G.
• 31.9. IntraBio Inc.
• 31.10. National Niemann-Pick Disease Foundation (NNPDF)
• 31.11. Bloomsbury Genetic Therapies Ltd.
• 31.12. CTD Holdings Inc.
• 31.13. Okklo Life Sciences
• 31.14. Vtesse Inc.
• 31.15. Cyclo Therapeutics Inc.

32. Global Niemann-Pick Disease Type C Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Niemann-Pick Disease Type C Treatment Market

34. Recent Developments In The Niemann-Pick Disease Type C Treatment Market

35. Niemann-Pick Disease Type C Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Niemann-Pick Disease Type C Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Niemann-Pick Disease Type C Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Niemann-Pick Disease Type C Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34910_Niemann_Pick_Disease_Type_C_Treatment_GMR_2025